Growth of UK facility will enable clinical-grade manufacturing of drug substances for range of biopharmaceutical products BURLINGTON, Mass., Nov. 14, 2024 /PRNewswire/ -- SEKISUI Diagnostics' ...
BURLINGTON, Mass., Nov. 14, 2024 /PRNewswire/ -- SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback